Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 87193 | 27.4176 |
09:33 ET | 17030 | 27.5605 |
09:35 ET | 22799 | 27.52 |
09:37 ET | 9337 | 27.455 |
09:39 ET | 21617 | 27.26 |
09:42 ET | 40835 | 27.36 |
09:44 ET | 15407 | 27.3852 |
09:46 ET | 15427 | 27.33 |
09:48 ET | 13004 | 27.245 |
09:50 ET | 19861 | 27.25 |
09:51 ET | 11978 | 27.2406 |
09:53 ET | 6044 | 27.345 |
09:55 ET | 18779 | 27.475 |
09:57 ET | 7817 | 27.51 |
10:00 ET | 7524 | 27.5 |
10:02 ET | 34753 | 27.5 |
10:04 ET | 13844 | 27.555 |
10:06 ET | 8064 | 27.53 |
10:08 ET | 5143 | 27.51 |
10:09 ET | 25358 | 27.55 |
10:11 ET | 11313 | 27.495 |
10:13 ET | 5081 | 27.58 |
10:15 ET | 5360 | 27.53 |
10:18 ET | 9099 | 27.6 |
10:20 ET | 3896 | 27.55 |
10:22 ET | 4588 | 27.53 |
10:24 ET | 16869 | 27.4 |
10:26 ET | 6785 | 27.415 |
10:27 ET | 11363 | 27.4 |
10:29 ET | 15618 | 27.46 |
10:31 ET | 4914 | 27.44 |
10:33 ET | 11275 | 27.47 |
10:36 ET | 6940 | 27.54 |
10:38 ET | 4991 | 27.49 |
10:40 ET | 14338 | 27.54 |
10:42 ET | 11175 | 27.54 |
10:44 ET | 12554 | 27.495 |
10:45 ET | 4933 | 27.46 |
10:47 ET | 12302 | 27.51 |
10:49 ET | 3086 | 27.49 |
10:51 ET | 2490 | 27.52 |
10:54 ET | 4495 | 27.55 |
10:56 ET | 3810 | 27.52 |
10:58 ET | 3650 | 27.51 |
11:00 ET | 6122 | 27.4776 |
11:02 ET | 5505 | 27.42 |
11:03 ET | 4700 | 27.435 |
11:05 ET | 2907 | 27.45 |
11:07 ET | 1750 | 27.4966 |
11:09 ET | 4608 | 27.47 |
11:12 ET | 6787 | 27.54 |
11:14 ET | 25548 | 27.8 |
11:16 ET | 26745 | 27.855 |
11:18 ET | 13685 | 27.88 |
11:20 ET | 8378 | 27.79 |
11:21 ET | 3322 | 27.825 |
11:23 ET | 25556 | 27.925 |
11:25 ET | 10154 | 27.83 |
11:27 ET | 19377 | 27.9 |
11:30 ET | 9411 | 27.91 |
11:32 ET | 7202 | 27.865 |
11:34 ET | 7643 | 27.87 |
11:36 ET | 4013 | 27.88 |
11:38 ET | 3590 | 27.91 |
11:39 ET | 11860 | 27.985 |
11:41 ET | 11516 | 27.95 |
11:43 ET | 3656 | 27.92 |
11:45 ET | 14765 | 27.915 |
11:48 ET | 2440 | 27.8768 |
11:50 ET | 5073 | 27.87 |
11:52 ET | 1588 | 27.89 |
11:54 ET | 3402 | 27.94 |
11:56 ET | 1786 | 27.95 |
11:57 ET | 39901 | 28.015 |
11:59 ET | 23566 | 28.08 |
12:01 ET | 5960 | 28.075 |
12:03 ET | 12838 | 28.12 |
12:06 ET | 5215 | 28.135 |
12:08 ET | 4909 | 28.15 |
12:10 ET | 4622 | 28.11 |
12:12 ET | 5500 | 28.06 |
12:14 ET | 2827 | 27.9394 |
12:15 ET | 500 | 27.945 |
12:17 ET | 7826 | 28.02 |
12:19 ET | 2100 | 28.0301 |
12:21 ET | 9053 | 28.065 |
12:24 ET | 2250 | 28.07 |
12:26 ET | 2214 | 28.035 |
12:28 ET | 6511 | 28.12 |
12:30 ET | 5132 | 28.14 |
12:32 ET | 30645 | 28.05 |
12:33 ET | 5663 | 27.95 |
12:35 ET | 5001 | 28.03 |
12:37 ET | 4735 | 28.01 |
12:39 ET | 7683 | 28.0107 |
12:42 ET | 10407 | 28.14 |
12:44 ET | 7466 | 28.06 |
12:46 ET | 5941 | 28.08 |
12:48 ET | 2209 | 28.12 |
12:50 ET | 5337 | 28.18 |
12:51 ET | 10450 | 28.045 |
12:53 ET | 7891 | 28.12 |
12:55 ET | 2950 | 28.155 |
12:57 ET | 2366 | 28.195 |
01:00 ET | 8619 | 28.16 |
01:02 ET | 2718 | 28.1 |
01:04 ET | 1365 | 28.07 |
01:06 ET | 1112 | 28.08 |
01:08 ET | 2492 | 28.005 |
01:09 ET | 7417 | 28.045 |
01:11 ET | 1500 | 28.06 |
01:13 ET | 5543 | 28.04 |
01:15 ET | 2966 | 28.06 |
01:18 ET | 4696 | 28.1 |
01:20 ET | 1662 | 28.11 |
01:22 ET | 2331 | 28.1 |
01:24 ET | 4940 | 28.13 |
01:26 ET | 6966 | 28.1723 |
01:27 ET | 4910 | 28.17 |
01:29 ET | 11795 | 28.2 |
01:31 ET | 10700 | 28.21 |
01:33 ET | 10398 | 28.27 |
01:36 ET | 750 | 28.3 |
01:38 ET | 3401 | 28.28 |
01:40 ET | 21635 | 28.08 |
01:42 ET | 15052 | 28 |
01:44 ET | 3937 | 28.02 |
01:45 ET | 3829 | 28.05 |
01:47 ET | 4874 | 28.04 |
01:49 ET | 6103 | 28.075 |
01:51 ET | 3031 | 28.05 |
01:54 ET | 4519 | 28.06 |
01:56 ET | 7367 | 28.12 |
01:58 ET | 12117 | 28.08 |
02:00 ET | 6020 | 28.185 |
02:02 ET | 3075 | 28.1 |
02:03 ET | 4479 | 28.07 |
02:05 ET | 4296 | 28.05 |
02:07 ET | 5008 | 28.115 |
02:09 ET | 2600 | 28.1301 |
02:12 ET | 5348 | 28.11 |
02:14 ET | 6676 | 28.19 |
02:16 ET | 1604 | 28.185 |
02:18 ET | 3418 | 28.19 |
02:20 ET | 7087 | 28.21 |
02:21 ET | 4574 | 28.24 |
02:23 ET | 1955 | 28.255 |
02:25 ET | 8286 | 28.275 |
02:27 ET | 12878 | 28.34 |
02:30 ET | 4939 | 28.37 |
02:32 ET | 10665 | 28.415 |
02:34 ET | 8791 | 28.43 |
02:36 ET | 10233 | 28.45 |
02:38 ET | 15779 | 28.5 |
02:39 ET | 5105 | 28.53 |
02:41 ET | 36522 | 28.62 |
02:43 ET | 25521 | 28.59 |
02:45 ET | 11565 | 28.58 |
02:48 ET | 10095 | 28.61 |
02:50 ET | 9037 | 28.61 |
02:52 ET | 17306 | 28.62 |
02:54 ET | 41129 | 28.565 |
02:56 ET | 33320 | 28.62 |
02:57 ET | 30998 | 28.62 |
02:59 ET | 16269 | 28.67 |
03:01 ET | 27053 | 28.65 |
03:03 ET | 8530 | 28.675 |
03:06 ET | 17017 | 28.62 |
03:08 ET | 12354 | 28.62 |
03:10 ET | 6574 | 28.53 |
03:12 ET | 2876 | 28.54 |
03:14 ET | 9261 | 28.5103 |
03:15 ET | 13145 | 28.5783 |
03:17 ET | 6092 | 28.6 |
03:19 ET | 2475 | 28.5899 |
03:21 ET | 6120 | 28.53 |
03:24 ET | 3406 | 28.55 |
03:26 ET | 9628 | 28.582 |
03:28 ET | 50894 | 28.53 |
03:30 ET | 14093 | 28.5 |
03:32 ET | 16554 | 28.51 |
03:33 ET | 11967 | 28.5499 |
03:35 ET | 9175 | 28.55 |
03:37 ET | 7392 | 28.565 |
03:39 ET | 16457 | 28.6 |
03:42 ET | 4706 | 28.59 |
03:44 ET | 11911 | 28.625 |
03:46 ET | 15613 | 28.6234 |
03:48 ET | 11566 | 28.59 |
03:50 ET | 13171 | 28.72 |
03:51 ET | 23087 | 28.62 |
03:53 ET | 38667 | 28.64 |
03:55 ET | 42247 | 28.7 |
03:57 ET | 97206 | 28.92 |
04:00 ET | 496358 | 28.81 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 4.3B | -270.1x | --- |
Axsome Therapeutics Inc | 4.4B | -13.8x | --- |
ADMA Biologics Inc | 4.6B | 160.9x | --- |
Denali Therapeutics Inc | 4.2B | -11.3x | --- |
CRISPR Therapeutics AG | 4.4B | -18.4x | --- |
Alvotech SA | 3.8B | -4.8x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
---|---|
Revenue (TTM) | $264.8M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.18 |
EPS | $-0.11 |
Book Value | $1.06 |
P/E Ratio | -270.1x |
Price/Sales (TTM) | 16.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -0.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.